Location: Home
  • search
  • go
  • Relate News
  • 3/20/2026ELCC 2026: BioKin–Henlius Combo Shows First-Line Promise in ES-SCLC
  • 3/20/2026NovaBridge Secures FDA Alignment on Accelerated Pathway for Givastomig...
  • 3/20/2026Excalipoint Launches With $68.7M Seed to Advance Next-Generation TCE P...
  • 3/20/2026Kintor Reports Positive Phase III Results for First-in-Class Hair Loss...
  • 3/20/2026Cloudbreak Pharma Withdraws China IND for CBT-009, Refocuses Ophthalmo...
  • 3/20/2026Recent Executive Moves
  • 3/17/2026China Issues New Policy to Strengthen Primary Healthcare Through Medic...
  • 3/17/2026New NHSA Report Highlights Expanding Coverage and Reforms in China’s ...
  • 3/17/2026Fosun Pharma Subsidiary Secures China Approval for Novel Hair-Loss The...
  • 3/17/2026Essight Wins FDA Clearance for First Clinical Trial of RAS G12V Bispec...
  • 3/17/2026CDE Seeks Comment on Draft Guideline for Advancing Oncology Drugs to F...
  • 3/17/2026CDE Issues Guideline on Dose Extrapolation for Neonates and Young Infa...
  • 3/17/2026Merck KGaA Aims to Deepen Partnerships in China's Pharmaceutical Innov...
  • 3/17/2026PegBio Partners With Tenry Pharma to Commercialize Paidakang in Mainla...
  • 3/17/2026Gyre Thera Liver Fibrosis Drug Receives Priority Review in China
  • 3/17/2026Innorna Wins FDA Clearance to Test mRNA Therapy for Refractory Gout in...
  • 3/17/2026NHSA: China Medical Insurance Revenue Growth Outpaces Spending in 2025
  • 3/17/2026China to Grant Market and Data Exclusivity for Innovative Drugs for th...
  • 3/17/2026US Reshoring Push Clouds Long-Term Outlook for China's Contract Drugma...
  • 3/16/2026CirCode Wins FDA Clearance to Test Circular RNA Therapy
  • 3/16/20263SBio Wins U.S. FDA Clearance to Advance Metabolic Disease Antibody SS...
  • 3/16/2026KangaBio Advances Oncology Pipeline with FDA IND Clearance
  • 3/13/2026UniXell Secures FDA Clearance to Begin Clinical Testing of iPSC-Derive...
  • 3/13/2026Jeyou Pharma Raises About CNY 2B in Series A to Advance Clinical Pipel...
  • 3/13/2026Veristat Expands Regulatory and Clinical Trial Services for Chinese Dr...
  • 3/13/2026CMS Wins NMPA Approval for Desidustat Tablets to Treat Renal Anemia
  • 3/13/2026China Private Biotech Financing Slows in February but Larger Deals Sig...
  • 3/12/2026China's Labs Race for the Next First-in-Class Breakthrough
  • 3/12/2026Hansoh Launches Phase 3 Trial of B7-H3 ADC HS-20093 With PD-L1 Therapy...
  • 3/12/2026Eli Radiopharma Raises ~CNY 100M to Advance Theranostics Pipeline
  • Page:9/830 Total number of articles:24896: [First][<<] [7] [8] [9] [10] [11] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group